fig5

Peptide nucleic acid-based targeting of microRNAs: possible therapeutic applications for glioblastoma

Figure 5. A: Structure of the macrocyclic multivalent tetraargininocalix[4]arene 1 used as non-covalent vector for anti-miRNA PNAs; B,C: Effects of compound 1 on morphology of U251 glioma cells: lack of cytotoxic effects. D. Effects of free PNA (a221-PNA) and a221-PNA delivered with compound 1 on miR-221-3p in treated U251 cells. Inhibition of miR-221-3p expression is obtained only when a221-PNA is vehiculated by compound 1. Modified from Gasparello et al.[125]

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/